Processes and outcomes of care for patients with community-acquired pneumonia - Results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study

被引:224
作者
Fine, MJ
Stone, RA
Singer, DE
Coley, CM
Marrie, TJ
Lave, JR
Hough, LJ
Obrosky, DS
Schulz, R
Ricci, EM
Rogers, JC
Kapoor, WN
机构
[1] Univ Pittsburgh, Ctr Res Hlth Care, Pittsburgh, PA USA
[2] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA
[3] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Serv Adm, Pittsburgh, PA 15261 USA
[4] Univ Pittsburgh, Dept Med, Div Gen Internal Med, Pittsburgh, PA 15261 USA
[5] Harvard Univ, Sch Med, Boston, MA USA
[6] Massachusetts Gen Hosp, Dept Med, Div Gen Internal Med, Boston, MA 02114 USA
[7] Dalhousie Univ, Halifax, NS, Canada
[8] Queen Elizabeth 2 Hlth Sci Ctr, Dept Med, Halifax, NS, Canada
[9] Queen Elizabeth 2 Hlth Sci Ctr, Dept Microbiol, Halifax, NS, Canada
关键词
D O I
10.1001/archinte.159.9.970
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Although understanding the processes of care and medical outcomes for patients with community-acquired pneumonia is instrumental to improving the quality and cost-effectiveness of care for this illness, limited information is available on how physicians manage patients with this illness or on medical outcomes other than short-term mortality. Objectives: To describe the processes of care and to assess a broad range of medical outcomes for ambulatory and hospitalized patients with community-acquired pneumonia. Methods: This prospective, observational study was conducted at 4 hospitals and 1 health maintenance organization in Pittsburgh, Pa, Boston, Mass, and Halifax, Nova Scotia. Data were collected via patient interviews and reviews of medical records for 944 outpatients and 1343 inpatients with clinical and radiographic evidence of community-acquired pneumonia. Processes of care and medical outcomes were assessed 30 days after presentation. Results: Only 29.7% of outpatients had 1 or more microbiologic tests performed, and only 5.7% had an assigned microbiologic cause. Although 95.7% of inpatients had 1 or moro microbiologic tests performed, a cause was established in only 29.6%. Six outpatients (0.6%) died, and 3 of these deaths were pneumonia related. Of surviving outpatients, 8.0% had 1 or more medical complications. At 30 days, 88.9% (nonemployed) to 95.6% (employed) of the surviving outpatients had returned to usual activities, yet 76.0% of outpatients had 1 or more persisting pneumonia-related symptoms. Overall, 107 inpatients (8.0%) died, and 81 of these deaths were pneumonia related. Most surviving inpatients (69.0%) had 1 or more medical complications. At 30 days, 57.3% (nonemployed) to 82.0% (employed) of surviving inpatients had returned to usual activities, and 86.1% had 1 or more persisting pneumonia-related symptoms. Conclusions: In this study, conducted primarily at hospital sites with affiliated medical education training programs, virtually all outpatients and most inpatients had pneumonia of unknown cause. Although outpatients had an excellent prognosis, pneumonia-related symptoms often persisted at 30 days. Inpatients had substantial mortality, morbidity, and pneumonia-related symptoms at 30 days.
引用
收藏
页码:970 / 980
页数:11
相关论文
共 38 条
[1]  
Adams P, 1995, VITAL HLTH STAT
[2]   Interobserver reliability of the chest radiograph in community-acquired pneumonia [J].
Albaum, MN ;
Hill, LC ;
Murphy, M ;
Li, YH ;
Fuhrman, CR ;
Britton, CA ;
Kapoor, WN ;
Fine, MJ .
CHEST, 1996, 110 (02) :343-350
[3]  
[Anonymous], 1997, INT CLASSIFICATION D
[4]   INFLUENCE OF BLOOD CULTURE RESULTS ON ANTIBIOTIC CHOICE IN THE TREATMENT OF BACTEREMIA [J].
ARBO, MDJ ;
SNYDMAN, DR .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (23) :2641-2645
[5]   Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients - An interventional trial [J].
Atlas, SJ ;
Benzer, TI ;
Borowsky, LH ;
Chang, YC ;
Burnham, DC ;
Metlay, JP ;
Halm, EA ;
Singer, DE .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (12) :1350-1356
[6]  
Bartlett J G, 1970, Antimicrob Agents Chemother (Bethesda), V10, P78
[7]   COMMUNITY-ACQUIRED PNEUMONIA [J].
BARTLETT, JG ;
MUNDY, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) :1618-1624
[8]   Community-acquired pneumonia in adults: Guidelines for management [J].
Bartlett, JG ;
Breiman, RF ;
Mandell, LA ;
File, TM .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) :811-838
[9]   ETIOLOGY OF COMMUNITY-ACQUIRED PNEUMONIA IN OUT-PATIENTS [J].
BERNTSSON, E ;
LAGERGARD, T ;
STRANNEGARD, O ;
TROLLFORS, B .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (04) :446-447
[10]   ETIOLOGY OF COMMUNITY ACQUIRED PNEUMONIA IN VALENCIA, SPAIN - A MULTICENTER PROSPECTIVE-STUDY [J].
BLANQUER, J ;
BLANQUER, R ;
BORRAS, R ;
NAUFFAL, D ;
MORALES, P ;
MENENDEZ, R ;
SUBIAS, I ;
HERRERO, L ;
REDON, J ;
PASCUAL, J .
THORAX, 1991, 46 (07) :508-511